Resources

Publications

05/12/2025
- Oncology
Comparison of Demographics and Clinical Characteristics Using Real World Data from Tempus Multimodal Database and SEER Cancer Registry Across 17 Solid Cancer Cohorts
ISPOR 2025
05/12/2025
- Oncology
Oncology Trial Emulation Using Real-World Electronic Health Record Data: Results of the Coalition to Advance Real-World Evidence Through Randomized Controlled Trial Emulation (CARE) Initiative
ISPOR 2025
05/12/2025
- Clinical Trials
AI-Driven Predictive Biomarker Discovery With Contrastive Learning To Improve Clinical Trial Outcomes
Cancer Cell
05/08/2025
- Oncology
Molecular Landscape of Patients (Pts) With Metastatic Breast Cancer (mBC) Who Progressed on Second-Line (2L) Selective Estrogen Receptor Degraders (SERDs)
ESMO BC 2025
05/02/2025
- Oncology
A Phase I, Open-Label, Multicentre, First-in-Human Study to Evaluate Safety, Pharmacokinetics and Efficacy of AMG 404, a PD-1 Inhibitor, in Patients With Advanced Solid Tumours
BMJ Open
05/01/2025
- Oncology
Baseline Biomarker Analyses of Patients With Chemorefractory KRAS G12C-Mutated Metastatic Colorectal Cancer (mCRC) From the Phase 3 CodeBreaK 300 Study
AACR 2025
05/01/2025

Real-World Experience of the Clinical Correlation Between ARID Gene Alterations /RNA Expression Levels and Treatment Benefit of Immunotherapy in Malignant Solid Tumors
AACR 2025
05/01/2025
- Oncology
Analysis of multimodal real world data from 1,248 breast cancer patients reveals distinct, novel consensus molecular segments associated with CDK4/6 inhibitor resistance
AACR 2025
05/01/2025
- Oncology
Enhancing TCR-T With a Fas-Based Switch Receptor Boosts T Cell Engraftment, Persistence, and Anti-Tumor Activity in Models of Hard-To-Treat PRAME Solid Tumor Indications
AACR 2025
05/01/2025
- Oncology
CLSP-1025, a First-in-Class Precision T Cell Engager for the Treatment of p53 Mutant Cancers
AACR 2025

5 6 7